Hosted on MSN3h
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
Essential gene map of malaria parasite Plasmodium knowlesi aids in treatment design
A new, comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite ...
FierceBiotech10h
Denali eyes approval after Hunter syndrome drug clears safety measures, reduces biomarkers in open-label study
After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...
Dear Doctor: How is the autoimmune disease pernicious anemia (PA) treated?
A person who has the type of anemia with B12 deficiency and low B12 levels (called "megaloblastic anemia" with unusual white ...
Dr. Roach: Fatigue and tingling persist during treatment
Dear M.P.: Pernicious anemia (PA) is an autoimmune disease where the body destroys the cells in the stomach that make ...
Drug Similar to Ozempic Failed to Treat Parkinson’s Disease in a Trial
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
Why SARS-CoV-2 bounces back after antiviral treatment
The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...
Science Daily2d
Improved treatment timing reduces honey bee losses to Varroa mites
Honey bee mortality can be significantly reduced by ensuring that treatments for the parasitic Varroa mite occur within specific timeframes, a new study reveals.